Top Markets
Coin of the day
Quantum Genomics S.A. Quantum Genomics S.A.

Quantum Genomics S.A.

ALQGC
Classificação em ações #37063
Quantum Genomics S.A., a biopharmaceutical firm established in Paris, France,... Quantum Genomics S.A., a biopharmaceutical firm established in Paris, France, in 2005, focuses on creating treatments for cardiovascular ailments. Its therapeutic approach utilizes the brain aminopeptidase A inhibition (BAPAI) platform, primarily addressing high blood pressure (hypertension) and heart failure. The company's key asset, firibastat, is currently undergoing a crucial Phase III study as a standalone therapy for hypertension and is also in clinical trials for heart failure. Additionally, Quantum Genomics is progressing QGC011 for hypertension in combination therapy, and further developing QGC006 and QGC606 to target both hypertension and heart failure.
Preço da ação
$0.07600875
Última sincronização: 2024-11-20
Valor de mercado
$2.06M
Variação (1 dia)
-0.51%
Variação (1 ano)
0.00%
País
FR
Negociar Quantum Genomics S.A. (ALQGC)

Categoria

EPS de Quantum Genomics S.A. (ALQGC)
EPS em December 2024 TTM: $-0.26
De acordo com os últimos relatórios financeiros e o preço das ações da Quantum Genomics S.A., o EPS atual da empresa (TTM) é $-0.26. No final de 2023, a empresa teve um EPS de $-0.10, uma diminuição em relação a ao EPS de 2022, que foi de $-0.77.
Histórico de EPS da Quantum Genomics S.A. de 2009 até 2026
EPS no final de cada ano
Ano EPS Alterar
2026 (TTM) $-0.26 85.79%
2024 $-0.14 34.49%
2023 $-0.10 -86.97%
2022 $-0.77 6.11%
2021 $-0.73 -24.35%
2020 $-0.96 71.50%
2019 $-0.56 -35.77%
2018 $-0.87 -15.36%
2017 $-1.03 55.66%
2016 $-0.66 13.06%
2015 $-0.59 5.34%
2014 $-0.56 9.39%
2013 $-0.51 1.50%
2012 $-0.50 -89.65%
2011 $-4.84 -37.57%
2010 $-7.75 -10.46%
2009 $-8.66 0.00%
EPS de empresas semelhantes ou concorrentes
Empresa EPS Diferença de EPS País
$17.32 -6,758.98%
US
$27.74 -10,765.13%
NL
- -
CH
- -
KR
$13.70 -5,367.24%
BE